Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Bioactive phytochemicals that regulate the cellular processes involved in diabetic nephropathy.
Amna Parveen1, Mirim Jin2, Sun Yeou Kim3
1Department of Pharmacognosy, College of Pharmacy, Government College University Faisalabad, Faisalabad, Pakistan; Gachon Institute of Pharmaceutical Science, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea.
Medicinal plants and their compounds show promise in managing diabetic nephropathy (DN) by targeting key cellular pathways. Further research is needed to confirm their efficacy in preclinical models and humans.
Area of Science:
- Pharmacology
- Nephrology
- Phytochemistry
Background:
- Diabetic nephropathy (DN) treatments are limited by multiple causative factors and adverse effects of synthetic drugs.
- Medicinal plants and their bioactive compounds offer a safer, more effective alternative for managing chronic diseases like DN.
- Natural products are increasingly recognized for their potential in addressing the complex pathology of DN.
Purpose of the Study:
- To review medicinal plants and their bioactive phytochemicals that regulate cellular processes in DN initiation.
- To explore natural products as a therapeutic strategy for diabetic nephropathy.
- To identify plant-derived compounds that target key pathways involved in DN.
Main Methods:
- Comprehensive literature search of electronic databases (Embase, Google Scholar, PubMed, Scopus, Science Direct).
- Focused on English-language works concerning phytochemicals and medicinal plants for DN amelioration.
- Analysis of studies detailing the regulation of cellular processes in DN by plant-derived compounds.
Main Results:
- Medicinal plants contain bioactive constituents that can slow DN progression and improve renal function.
- These compounds target multiple pathological pathways including p38MAPK, JNK, ERK, TGF-β, RhoA, NF-κB, Wnt, JAK-STAT, AMPK, mTOR, Akt, and TXNIP.
- Inhibiting these pathways with plant-derived agents may offer significant therapeutic benefits for DN.
Conclusions:
- Traditional herbs and their bioactive constituents demonstrate pharmacological activities regulating DN cellular processes.
- The efficacy of these natural compounds in animal models and humans requires further investigation.
- Preclinical and clinical studies are essential to evaluate the nephroprotective effects of medicinal plants in diabetic nephropathy.
Related Concept Videos
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Master Transcription Regulators
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...
Bioactivation and Tissue Toxicity
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

